Structure–Activity Relationship (SAR) Studies of Heterocyclic Compounds as Potential Anticancer Agents.

Heterocyclic compounds constitute one of the most versatile and pharmacologically significant classes of molecules in anticancer drug discovery due to their diverse ring systems, tunable physicochemical properties, and ability to interact with multiple cancer‑related targets. Studies of the relationship between structure and activity play a central role in understanding how variations in ring size, the position of heteroatoms, substitution patterns, and electronic effects affect biological activity and therapeutic potential. These analyses allow for the systematic alteration of molecular frameworks in order to improve potency, selectivity, pharmacokinetics, and target affinity, thus speeding up rational drug design. Across nitrogen-, oxygen-, and sulfur‑containing heterocycles, SAR investigations have revealed that heteroatom placement and substituent orientation critically modulate interactions with key oncogenic pathways, including protein kinases, topoisomerases, tubulin, and apoptosis‑regulating proteins For instance, nitrogen-containing heterocycles such as benzimidazoles, quinazolines, and imidazoles show strong anticancer activity by means of kinase inhibition and DNA intercalation, since SAR studies have demonstrated that electron-withdrawing or donating groups considerably affect binding affinity and cytotoxicity. Just as with oxygen- and sulfur-containing heterocycles—such as coumarins, benzofurans, thiazoles, and thiazolidinediones—strong antiproliferative effects are observed, and modifications at certain positions on the ring increase the inhibition of microtubules, the induction of apoptosis, or the suppression of angiogenesis.